Taxim Injection 1 gm/10 ml contains Cefotaxime, a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity. It is specifically designed for the treatment of serious and severe bacterial infections in adults and pediatric patients. Its intravenous (IV) or intramuscular (IM) formulation ensures rapid systemic availability, providing effective and timely infection control.
Cefotaxime works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. Taxim Injection 1 gm/10 ml is particularly effective against both Gram-positive and Gram-negative bacteria, including strains resistant to earlier-generation cephalosporins. This formulation is ideal for hospitalized patients or those with severe infections requiring higher doses for optimal therapeutic outcomes.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Taxim Injection 1 gm/10 ml is indicated for the treatment of:
Severe respiratory tract infections, including pneumonia and bronchitis
Complicated urinary tract infections
Skin and soft tissue infections
Bone and joint infections
Septicemia and bacteremia caused by susceptible bacteria
Meningitis and other central nervous system infections where appropriate
Empiric therapy in serious infections where multi-drug resistant organisms are suspected
It is particularly recommended for hospitalized patients or individuals with infections that require prompt and aggressive antibiotic therapy.
Cefotaxime, the active ingredient in Taxim Injection, is a beta-lactam antibiotic. Its mechanism includes:
Inhibition of bacterial cell wall synthesis: Binds to penicillin-binding proteins (PBPs), preventing proper peptidoglycan cross-linking
Bactericidal activity: Leads to bacterial lysis and death
Broad-spectrum coverage: Effective against many Gram-positive and Gram-negative bacteria, including Escherichia coli, Klebsiella, Proteus, and certain strains of Pseudomonas
Beta-lactamase stability: Resistant to enzymatic degradation by many bacterial beta-lactamases, making it effective against resistant strains
This mechanism ensures rapid infection control and reduces the risk of bacterial proliferation.
Adults: Typically 1–2 grams every 8–12 hours, administered IV or IM depending on infection severity
Pediatric patients: Dosage is calculated based on body weight, usually 50–100 mg/kg/day divided into 2–4 doses
Renal impairment: Dose adjustment is required for patients with kidney dysfunction to prevent accumulation
Reconstitute the vial with sterile water or appropriate diluent according to manufacturer instructions
Administer IV slowly over 3–5 minutes or via infusion as directed by a healthcare professional
Use cautiously in patients with allergies to cephalosporins or penicillins due to potential cross-reactivity
Monitor renal and hepatic function during prolonged therapy
Antibiotic use may cause diarrhea, including Clostridium difficile-associated diarrhea; report persistent diarrhea promptly
Patients should inform healthcare providers of all medications to avoid interactions, including aminoglycosides and anticoagulants
Taxim Injection 1 gm/10 ml is generally well tolerated. Common side effects include:
Injection site pain, redness, or irritation
Nausea, vomiting, or mild diarrhea
Headache or dizziness
Rare but serious effects: allergic reactions, hematologic abnormalities, nephrotoxicity, or superinfections
Seek immediate medical attention if severe allergic reactions or signs of worsening infection occur.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Store below 30°C in a cool, dry place, away from direct sunlight. Keep the vial tightly closed and out of reach of children. Reconstituted solutions should be used immediately or stored according to manufacturer instructions.
Taxim Injection 1 gm/10 ml provides powerful broad-spectrum antibacterial therapy for severe bacterial infections, ensuring rapid and effective treatment under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet